FI92826B - Förfarande för framställning av 3R-(3-karboxibensyl)-6-(5-fluor-2-bensotiazolyl)metoxi-4R-kromanol genom optisk resolution - Google Patents
Förfarande för framställning av 3R-(3-karboxibensyl)-6-(5-fluor-2-bensotiazolyl)metoxi-4R-kromanol genom optisk resolution Download PDFInfo
- Publication number
- FI92826B FI92826B FI903861A FI903861A FI92826B FI 92826 B FI92826 B FI 92826B FI 903861 A FI903861 A FI 903861A FI 903861 A FI903861 A FI 903861A FI 92826 B FI92826 B FI 92826B
- Authority
- FI
- Finland
- Prior art keywords
- salt
- quinine
- benzothiazolyl
- fluoro
- carboxybenzyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Claims (4)
1. Förfarande för framställning av 3R-(3-karboxi-bensyl)-6-(5-fluor-2-bensotiazolyl)metoxi-4R-kromanol el- 5 ler ett famaceutiskt godtagbart sait därav, vilken före-ning har formeln (I) OH - - COOH kännetecknat därav, att a) racemisk cis-3-(3-karboxibensyl)-6-(5-fluor-2- 15 bensotiazolyl)metoxi-4-kromanol kombineras med ätminstone hälften av dess molmängd av kinin i metanol vid en tempe-ratur, som är inom omrädet ca 20 - 65 °C, i en sädan kon-centration, att kininsaltet av föreningen med formeln (I) kristalliseras väsentligen fritt av kininsaltet av före-20 ningens (I) enantiomer; b) nämnda kininsalt av föreningen med formeln (I) tillvaratas pä sedvanligt sätt; och c) nämnda kininsalt acidifieras pä sedvanligt sätt med en syra i ett reaktionsinert lösningsmedel, varvid man \ 25 erhäller nämnda förening med formeln (I).
2. Förfarande enligt patentkrav 1, kännetecknat därav, att molmängden av kinin är inom omrädet ca 0,5 - 1,5 mol.
3. Förfarande enligt patentkrav 1, k ä n n e - 30 tecknat därav, att kininsaltet av föreningen med formeln (I) isoleras vid rumstemperatur frän metanol, som används i en mängd av ca 20 - 30 ml per gram av den i för-farandet använda racemiska föreningen.
4. Kininsalt av 3R-(3-karboxibensyl)-6-(5-fluor-2- 35 bensotiazolyl)metoxi-4R-kromanol. Il
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38971589 | 1989-08-04 | ||
| US07/389,715 US4987231A (en) | 1989-08-04 | 1989-08-04 | Optical resolution method for 3R-(3-carboxybenzyl)-6-(5-fluoro-2-benzothiazolyl)methoxy-4R-chromanol |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI903861A0 FI903861A0 (sv) | 1990-08-03 |
| FI92826B true FI92826B (sv) | 1994-09-30 |
| FI92826C FI92826C (sv) | 1995-01-10 |
Family
ID=23539421
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI903861A FI92826C (sv) | 1989-08-04 | 1990-08-03 | Förfarande för framställning av 3R-(3-karboxibensyl)-6-(5-fluor-2-bensotiazolyl)metoxi-4R-kromanol genom optisk resolution |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US4987231A (sv) |
| EP (1) | EP0411813A1 (sv) |
| JP (1) | JPH0374384A (sv) |
| KR (1) | KR920011021B1 (sv) |
| CN (1) | CN1024550C (sv) |
| AU (1) | AU613838B2 (sv) |
| CA (1) | CA2022611C (sv) |
| CZ (1) | CZ279737B6 (sv) |
| DD (1) | DD296924A5 (sv) |
| EG (1) | EG19125A (sv) |
| FI (1) | FI92826C (sv) |
| HU (1) | HUT58734A (sv) |
| IE (1) | IE902805A1 (sv) |
| IL (1) | IL95213A (sv) |
| MY (1) | MY105933A (sv) |
| NO (1) | NO903420L (sv) |
| NZ (1) | NZ234761A (sv) |
| PH (1) | PH26568A (sv) |
| PL (1) | PL164164B1 (sv) |
| PT (1) | PT94888A (sv) |
| RU (1) | RU1834889C (sv) |
| YU (1) | YU47369B (sv) |
| ZA (1) | ZA916126B (sv) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59198471A (ja) * | 1983-04-26 | 1984-11-10 | Canon Inc | 複写装置 |
| US5059609A (en) * | 1987-10-19 | 1991-10-22 | Pfizer Inc. | Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases |
| US5539128A (en) * | 1994-11-30 | 1996-07-23 | Pfizer Inc. | Processes and intermediates for preparing cis(+)3-[4,6-dihydroxy chroman-3-ylmethyl]-4-methoxyaniline |
| DE102014010979B3 (de) | 2014-07-29 | 2015-11-05 | Sew-Eurodrive Gmbh & Co Kg | Verwendung eines Anzeigemittels eines Umrichters, Verfahren zum Betreiben eines Umrichters und Umrichter |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA739471B (en) * | 1972-12-22 | 1974-08-28 | Hoffmann La Roche | Chromane derivatives |
| JPS5745185A (en) * | 1980-07-21 | 1982-03-13 | Eisai Co Ltd | Hydantoin derivative and its preparation |
| MX13485A (es) * | 1987-10-19 | 1993-05-01 | Pfizer | Procedimiento para obtener tetralinas, cromados y compuestos relacionados, sustituidos |
-
1989
- 1989-08-04 US US07/389,715 patent/US4987231A/en not_active Expired - Lifetime
-
1990
- 1990-07-20 PH PH40874A patent/PH26568A/en unknown
- 1990-07-25 EP EP90308122A patent/EP0411813A1/en not_active Withdrawn
- 1990-07-27 IL IL9521390A patent/IL95213A/en not_active IP Right Cessation
- 1990-08-01 JP JP2204937A patent/JPH0374384A/ja active Pending
- 1990-08-01 CZ CS903817A patent/CZ279737B6/cs unknown
- 1990-08-02 MY MYPI90001295A patent/MY105933A/en unknown
- 1990-08-02 PL PL90286327A patent/PL164164B1/pl unknown
- 1990-08-02 CA CA002022611A patent/CA2022611C/en not_active Expired - Fee Related
- 1990-08-02 DD DD90343216A patent/DD296924A5/de not_active IP Right Cessation
- 1990-08-02 PT PT94888A patent/PT94888A/pt not_active Application Discontinuation
- 1990-08-02 NZ NZ234761A patent/NZ234761A/xx unknown
- 1990-08-03 CN CN90106753A patent/CN1024550C/zh not_active Expired - Fee Related
- 1990-08-03 AU AU60191/90A patent/AU613838B2/en not_active Ceased
- 1990-08-03 ZA ZA916126A patent/ZA916126B/xx unknown
- 1990-08-03 KR KR1019900011921A patent/KR920011021B1/ko not_active IP Right Cessation
- 1990-08-03 FI FI903861A patent/FI92826C/sv not_active IP Right Cessation
- 1990-08-03 NO NO90903420A patent/NO903420L/no unknown
- 1990-08-03 RU SU904830536A patent/RU1834889C/ru active
- 1990-08-03 IE IE280590A patent/IE902805A1/en unknown
- 1990-08-03 HU HU904892A patent/HUT58734A/hu unknown
- 1990-08-04 EG EG46390A patent/EG19125A/xx active
- 1990-08-06 YU YU152290A patent/YU47369B/sh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL164164B1 (pl) | 1994-06-30 |
| AU6019190A (en) | 1991-02-07 |
| DD296924A5 (de) | 1991-12-19 |
| CN1024550C (zh) | 1994-05-18 |
| CA2022611C (en) | 1999-03-23 |
| CA2022611A1 (en) | 1991-02-05 |
| MY105933A (en) | 1995-02-28 |
| PL286327A1 (en) | 1991-03-25 |
| AU613838B2 (en) | 1991-08-08 |
| US4987231A (en) | 1991-01-22 |
| HU904892D0 (en) | 1991-01-28 |
| NO903420D0 (no) | 1990-08-03 |
| HUT58734A (en) | 1992-03-30 |
| YU152290A (sh) | 1992-09-07 |
| FI92826C (sv) | 1995-01-10 |
| IL95213A0 (en) | 1991-06-10 |
| EG19125A (en) | 1994-07-30 |
| PH26568A (en) | 1992-08-19 |
| IE902805A1 (en) | 1991-02-27 |
| KR920011021B1 (ko) | 1992-12-26 |
| FI903861A0 (sv) | 1990-08-03 |
| IL95213A (en) | 1995-01-24 |
| ZA916126B (en) | 1992-03-25 |
| YU47369B (sh) | 1995-01-31 |
| NO903420L (no) | 1991-02-05 |
| EP0411813A1 (en) | 1991-02-06 |
| KR910004610A (ko) | 1991-03-29 |
| CN1049160A (zh) | 1991-02-13 |
| RU1834889C (ru) | 1993-08-15 |
| PT94888A (pt) | 1991-04-18 |
| JPH0374384A (ja) | 1991-03-28 |
| NZ234761A (en) | 1991-09-25 |
| CZ279737B6 (cs) | 1995-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20080293965A1 (en) | Process for the Dynamic Resolution of (Substituted) (R)- or (S)- Mandelic Acid | |
| EP0672030B1 (en) | Process for preparing substantially pure enantiomers of phenylpropionic acids | |
| KR870001944B1 (ko) | 퀴놀린 카르복실산 유도체의 제조방법 | |
| FI92826B (sv) | Förfarande för framställning av 3R-(3-karboxibensyl)-6-(5-fluor-2-bensotiazolyl)metoxi-4R-kromanol genom optisk resolution | |
| JP2000327603A (ja) | プロピオン酸誘導体の製造方法 | |
| EA012420B1 (ru) | Улучшенный способ очистки периндоприла | |
| WO2004005241A1 (en) | Process for producing optically active amide | |
| JPH0352881A (ja) | テトロン酸アルキルエステルの製造方法 | |
| CN109956899B (zh) | 一种维生素b6的制备方法 | |
| JP2012506367A (ja) | 結晶性モンテルカストの塩 | |
| KR100564072B1 (ko) | α,α-디메틸벤질 시아나이드로부터 α,α-디메틸페닐아세트산을 비가압적으로 제조하는 방법 | |
| KR19990028490A (ko) | 사용완료된 반응 혼합물로부터 피발산을 분리하는 방법 | |
| JPH04334370A (ja) | ラセミおよび光学活性１，２，３，４−テトラヒドロイソキノリン−３−カルボン酸およびその前駆体の製造方法 | |
| KR100235376B1 (ko) | 2-아미노나프티리딘 유도체 그의 제조 방법 | |
| US4916226A (en) | Optical resolution method for 3S-(3-pyridylmethyl)-6-(2-quinolyl)-methoxy-4S-chromanol | |
| JP3911302B2 (ja) | 光学活性２−メチルピペラジンの製造法 | |
| NO165834B (no) | Fremgangsmaate for fremstilling av 2,3,4,5-tetrafluor-benzoyl-acetater. | |
| CN114591219A (zh) | S-3-氨基哌啶二盐酸盐的制备方法 | |
| TW202222790A (zh) | 製備4-溴呋喃-2-羧酸酯之方法 | |
| WO2004113321A1 (ja) | 選択的なアミノ置換基導入法 | |
| JPH07145162A (ja) | ４ｈ−ピラン−４−オンの製造方法 | |
| FR2567881A1 (fr) | Procede pour la production d'un derive de pyrrolidine | |
| JPH0585985A (ja) | 光学活性なアトロラクチン酸の製造方法および製造の中間体 | |
| JP2003160560A (ja) | トランス−４−置換ピペリジン−２−カルボン酸塩類の製造方法 | |
| HU218467B (hu) | Eljárás homokirális alkoholok előállítására |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application | ||
| FG | Patent granted |
Owner name: PFIZER INC. |
|
| MA | Patent expired |